MedCap AB (publ)
STO:MCAP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
MedCap AB (publ)
Operating Income
MedCap AB (publ)
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
MedCap AB (publ)
STO:MCAP
|
Operating Income
kr302.9m
|
CAGR 3-Years
23%
|
CAGR 5-Years
30%
|
CAGR 10-Years
44%
|
|
|
AddLife AB
STO:ALIF B
|
Operating Income
kr10.4B
|
CAGR 3-Years
132%
|
CAGR 5-Years
72%
|
CAGR 10-Years
N/A
|
|
|
BICO Group AB
STO:BICO
|
Operating Income
-kr249.7m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
|
|
A
|
AroCell AB (publ)
STO:AROC
|
Operating Income
-kr12m
|
CAGR 3-Years
41%
|
CAGR 5-Years
13%
|
CAGR 10-Years
-5%
|
|
|
Biotage AB
STO:BIOT
|
Operating Income
kr327m
|
CAGR 3-Years
4%
|
CAGR 5-Years
8%
|
CAGR 10-Years
16%
|
|
|
G
|
Genovis AB
STO:GENO
|
Operating Income
kr21.3m
|
CAGR 3-Years
15%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
MedCap AB (publ)
Glance View
MedCap AB is an investment company engaged in biotechnology and medical technology capital investments. The company is headquartered in Solna, Stockholm. The company went IPO on 2006-07-04. The firm reports four segments: Abilia, Unimedic, Quickels and Inpac. The Company’s portfolio includes such companies as Abilia AB, which is engaged in the development and marketing of aids within the fields of communication, cognition, noise and environmental control; Unimedic AB, engaged in contract manufacturing of liquid pharmaceuticals; Quickels Systems AB, which is engaged in the development and marketing of intensive medical care equipment, such as care bags and electrocardiogram (ECG) equipment; AirContainer Package System AB that offers a wide range of packaging solutions for the pharmaceutical industry, and Dunmedic AB, which offers medical products, medicines and food supplements.
See Also
What is MedCap AB (publ)'s Operating Income?
Operating Income
302.9m
SEK
Based on the financial report for Dec 31, 2025, MedCap AB (publ)'s Operating Income amounts to 302.9m SEK.
What is MedCap AB (publ)'s Operating Income growth rate?
Operating Income CAGR 10Y
44%
Over the last year, the Operating Income growth was 11%. The average annual Operating Income growth rates for MedCap AB (publ) have been 23% over the past three years , 30% over the past five years , and 44% over the past ten years .
